Dr. Geiersbach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-284-0161- Is this information wrong?
Summary
- Dr. Katherine Geiersbach is a molecular pathologist with expertise in genomic testing on solid tumors.
Education & Training
University of Utah HealthFellowship, Molecular Genetic Pathology, 2007 - 2008
University of ColoradoResidency, Pathology-Anatomic and Clinical, 2002 - 2005
Stanford Health CareInternship, Transitional Year, 2001 - 2002- University of Colorado School of Medicine Anschutz Medical CampusClass of 2001
Certifications & Licensure
MN State Medical License 2016 - 2024
UT State Medical License 2007 - 2018
CO State Medical License 2006 - 2009- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics
Publications & Presentations
PubMed
- Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experience.Tekin, B., Hofich, C., Pitel, B., Schoolmeester, J., Whaley, R., Raghunathan, A., Ebare, K., Stanton, M., Reynolds, J., Sharma, V., Thompson, R., Boorjian, S., Leibovi...> ;Human Pathology. 2023 Dec 23
- 2 citationsFrequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma.William R Sukov, Jain Zhou, Katherine B Geiersbach, Gary L Keeney, Jodi M Carter, J Kenneth Schoolmeester> ;Human Pathology. 2023 Jul 1
- 4 citationsRhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.Carina A Dehner, Katherine Geiersbach, Ross Rowsey, Paari Murugan, Stephen M Broski, Jeanne M Meis, Andrew E Rosenberg, Andrew L Folpe> ;Modern Pathology. 2023 Jun 1
- Join now to see all
Journal Articles
- Chromoanasynthesis Is a Common Mechanism That Leads to ERBB2 Amplifications in a Cohort of Early Stage HER2+ Breast Cancer SamplesKatherine B Geiersbach, Mitesh J Borad, Sarah A McLaughlin, BioMed Central
Lectures
- Reassignment of HER2 status for subgroups of breast cancer according to the 2018 updated American Society of Clinical Oncology and College of American Pathologists gui...2019 ASCO Annual Meeting - 6/1/2019
- 26th Annual Park City Combined AP/CP Pathology UpdateARUP Laboratories, Park City, Utah - 2/4/2013
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
